EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology

Oksana Sulaieva iD, Nazarii Kobyliak, Ihor Panko, Tetiana Meged, Olena Gaidamak, Maksym Pogorielov iD, Volodymyr Deineka iD

ACS Applied Bio Materials · 17.11.2025 · 8 (11) · 9542-9556

DOI: 10.1021/acsabm.5c00982 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Applied Bio Materials, online erschienen am 07.11.2025. Verfasst von Oksana Sulaieva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory CSD, Kyiv 03022, Ukraine. Hauptthemen laut MEDLINE: Tumor Microenvironment, Antineoplastic Agents, Neoplasms, Biocompatible Materials. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, MSCA4Ukraine project I-NanoTerm, LRC Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of two-dimensional (2D) nanomaterials such as MXenes has significantly expanded opportunities in precision oncology. With their high surface area, tunable surface chemistry, strong photothermal conversion efficiency, and intrinsic biocompatibility, MXenes offer promising potential for cancer nanotheranostics. This review explores the therapeutic applications of MXenes, focusing on their dual roles in direct tumor ablation and modulation of the tumor immune microenvironment (TIME). MXenes exert anticancer effects through reactive oxygen species-mediated cytotoxicity and localized photothermal heating while also influencing immune cell function and tumor-immune interactions. Recent studies using single-cell sequencing and high-dimensional immune profiling highlight the capacity of MXenes to modulate immune-mediated tumor cell death. Their selective reactivity in the acidic tumor milieu, linked to the Warburg effect, makes them ideal candidates for pH-responsive drug delivery. We further discuss synergistic strategies combining MXene-based photothermal therapy with chemotherapy, targeted agents, and immunotherapies. Advancing MXene-based cancer therapies requires an integrated understanding of tumor biology, metabolic reprogramming, and TIME dynamics. This multidisciplinary approach is essential for the development of safe, selective, and personalized nanomedicine platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentAntineoplastic AgentsNeoplasmsBiocompatible MaterialsNanostructuresHumansAnimalsMaterials Testing

Stichwörter der Autor:innen

MXeneMXene functionalizationcancer therapydrug deliverytarget therapytumor immune microenvironment

Substanzen

Antineoplastic AgentsBiocompatible Materials

Autor:innen und Institutionen

  • Medical Laboratory CSD, Kyiv 03022, Ukraine.
  • Kyiv Medical University, Kyiv 02099, Ukraine.
  • Ukrainian Association of Precision Medicine, Kyiv 03117, Ukraine.
  • Bogomolets National Medical University, Kyiv 01601, Ukraine.
  • Sumy State University, Sumy 40014, Ukraine.
  • University of Latvia, Riga LV-1586, Latvia.

ORCID-Profile: Oksana Sulaieva, Maksym Pogorielov, Volodymyr Deineka

Förderung

  • HORIZON EUROPE Marie Sklodowska-Curie Actions
  • MSCA4Ukraine project I-NanoTerm
  • LRC Project

Zitieren

APA

Sulaieva, O., Kobyliak, N., Panko, I., Meged, T., Gaidamak, O., Pogorielov, M., & Deineka, V. (2025). Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology. ACS Applied Bio Materials, 8(11), 9542-9556. https://doi.org/10.1021/acsabm.5c00982

Vancouver

Sulaieva O, Kobyliak N, Panko I, Meged T, Gaidamak O, Pogorielov M, et al. Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology. ACS Applied Bio Materials. 2025;8(11):9542-9556. doi:10.1021/acsabm.5c00982

BibTeX
@article{Sulaieva2025,
  author = {Sulaieva, Oksana and Kobyliak, Nazarii and Panko, Ihor and Meged, Tetiana and Gaidamak, Olena and Pogorielov, Maksym and Deineka, Volodymyr},
  title = {Biological and Therapeutic Potentials of MXenes in Tumor Microenvironment-Driven Oncology},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  volume = {8},
  number = {11},
  pages = {9542--9556},
  doi = {10.1021/acsabm.5c00982}
}
Kostenlos starten →